Publications by authors named "Inge M Svane"

Claim this Profile
N
Nationwide Real-World Outcomes of Trial Eligible and Trial Ineligible Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.
Mette Syberg Jespersen, Jesper Andreas Evers Palshof, Niels Fristrup, Niels Viggo Jensen, Jon Røikjær Henriksen, Inge Marie Svane

Clin Genitourin Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.
Sidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite, Cathrine Lund Lorentzen, Julie Westerlin Kjeldsen, Inge Marie Svane

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma.
Rasmus Haunstrup Døssing, Elisabeth Hesselberg, Anna Burton Clausen, Adam Andrzej Luczak, Mario Presti, Inge Marie Svane

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering.
Michael D Crowther, Joel E Sohlin, Inge Marie Svane, Özcan Met

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, Kevin James Baker, Milou Schattefor, Inge Marie Svane

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological immune-related adverse events after ICI treatment: a protocol for an overview of systematic reviews.
Mai Erritzøe-Jervild, Christian Gunge Riberholt, Anders Hougaard, Christian Stenør, Inge Marie Svane

BMJ Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical response during anti-PD-1 immunotherapies.
Elisa Catafal-Tardos, Lola Dachicourt, Maria Virginia Baglioni, Marcelo Gregorio Filho Fares da Silva, Davide Secci, Inge Marie Svane

EMBO Mol Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroid-refractory severe immune-related mucositis following adjuvant anti-PD-1 therapy for resectable melanoma: a case report.
Sidsel Pedersen, Troels Holz Borch, Inge Marie Svane, Marco Donia, Eva Ellebaek

Melanoma Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study.
Emilie Kristine Dahl, Katrine Risager Christensen, Henrik Albæk Jacobsen, Anders Kverneland, Anders Dige, Inge Marie Svane

JCO Oncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.
Yago Garitaonaindia, Shawez Khan, Rasmus Friis, Søren Kjær, Troels H Borch, Inge Marie Svane

J Natl Cancer Inst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma.
Cecilie Dam Vestergaard, Eva Ellebaek, Troels Holz Borch, Marco Donia, Inge Marie Svane

Am J Clin Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.
Mees D Egeler, Sebastian Klobuch, Willemijn S Tak, Maartje W Rohaan, Troels H Borch, Inge Marie Svane

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab.
Inge Mansfield Noringriis, Marco Donia, Kasper Madsen, Henrik Schmidt, Charlotte Aaquist Haslund, Inge Marie Svane

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomics.
Anders Handrup Kverneland, Ole Østergaard, Joel Emanuel Sohlin, Inge Mansfield Noringriis, Rebecca S Jurlander, Inge Marie Svane

BMJ Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.
Michael Weichenthal, Eva Ellebaek, Joanna Mangana, Nethanel Asher, Iva Gavrilova, Inge Marie Svane

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma.
Cecilie D Vestergaard, Marco Donia, Kasper Madsen, Henrik Schmidt, Adam A Luczak, Inge M Svane

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking tumor-infiltrating lymphocyte potential with CRISPR-Cas9.
Özcan Met, Inge Marie Svane

Lancet Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
Tine J Monberg, Santeri A Pakola, Benedetta Albieri, Eva Ellebaek, Marco Donia, Inge Marie Svane

Cell Rep Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkers.
Eva Ellebaek, Marco Donia, Inge Marie Svane

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022).
Sidsel Pedersen, Emma Lund Johansen, Karen Louise Højholt, Marie Wett Pedersen, Anne Mark Mogensen, Inge Marie Svane

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma.
Tine Gadegaard Hindso, Torben Martinussen, Camilla Wium Bjerrum, Sune Høgild Keller, Annika Loft, Inge Marie Svane

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.
Kalijn Fredrike Bol, Mark Wilhelmus Dirk Sweep, Michael Douglas Crowther, Mark Antonius Johannes Gorris, Pedro Aroca Lara, Inge Marie Svane

Invest Ophthalmol Vis Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling.
Maria Perez-Penco, Mikkel Byrdal, Lucia Lara de la Torre, Marta Ballester, Shawez Khan, Inge Marie Svane

Cell Mol Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes.
Cecilie Oelvang Madsen, Marta Velasco Santiago, Evelina Martinenaite, Troels Holz Borch, Marco Donia, Inge Marie Svane

Clin Exp Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression for Tailoring Treatment in Advanced Melanoma-It Is Never That Easy-Reply.
Marco Donia, Inge Marie Svane

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis